Achieve Life Sciences Inc (ACHV)
Fair Value-38.2% Downside
Overvalued
Analyst111.6% Upside
Market Cap664.2 M
P/E-13.2x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
High-Beta Momentum
Small-Cap Stocks
Myriad Genetics Inc (MYGN)
Fair Value47.6% Upside
Undervalued
Analyst68.9% Upside
Market Cap303.2 M
P/E-2.7x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
High-Beta Momentum
Small-Cap Stocks
Eledon Pharmaceuticals Inc (ELDN)
Fair Value-6.9% Downside
Fair
Analyst161.6% Upside
Market Cap269.8 M
P/E-3.4x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
High-Beta Momentum
Travere Therapeutics Inc (TVTX)
Fair Value-4.0% Downside
Fair
Analyst8.9% Upside
Market Cap5.281 B
P/E-78.0x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Rapid Revenue Growth
High-Beta Stocks
High-Momentum Stocks
High-Beta Momentum
Abeona Therapeutics Inc (ABEO)
Fair Value6.8% Upside
Fair
Analyst189.9% Upside
Market Cap388.7 M
P/E5.9x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Beta Stocks
High-Momentum Stocks
High-Beta Momentum
Small-Cap Stocks
Avalo Therapeutics Inc (AVTX)
Fair Value-7.3% Downside
Fair
Analyst137.2% Upside
Market Cap980.3 M
P/E-11.8x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
High-Momentum Stocks
High-Beta Momentum
Small-Cap Stocks
Fennec Pharmaceuticals Inc (FENC)
Fair Value12.7% Upside
Fair
Analyst48.9% Upside
Market Cap351.2 M
P/E-43.6x
Yield0.0%
HealthGreat
NASDAQ
Featured in
High-Beta Stocks
High-Momentum Stocks
High-Beta Momentum
High-Growth Small-Cap Stocks
Small-Cap Stocks
Spyre Therapeutics Inc (SYRE)
Fair Value-50.8% Downside
Expensive
Analyst13.4% Upside
Market Cap9.228 B
P/E-61.7x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
High-Momentum Stocks
High-Beta Momentum
UroGen Pharma Ltd (URGN)
Fair Value-16.7% Downside
Fair
Analyst-3.6% Downside
Market Cap1.945 B
P/E-14.6x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
High-Momentum Stocks
High-Beta Momentum
Erasca Inc (ERAS)
Fair Value-18.7% Downside
Overvalued
Analyst22.4% Upside
Market Cap6.38 B
P/E-23.3x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
High-Beta Momentum
Monte Rosa Therapeutics Inc (GLUE)
Fair Value-1.8% Downside
Fair
Analyst96.5% Upside
Market Cap1.358 B
P/E-10.1x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
High-Beta Momentum
Small-Cap Stocks
Zentalis Pharmaceuticals Llc (ZNTL)
Fair Value13.8% Upside
Fair
Analyst34.7% Upside
Market Cap347.4 M
P/E-2.8x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Beta Stocks
High-Beta Momentum
High-Growth Small-Cap Stocks
Small-Cap Stocks
Alpha Cognition Inc (ACOG)
Fair Value9.5% Upside
Fair
Analyst87.8% Upside
Market Cap194.7 M
P/E-7.3x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Beta Stocks
High-Beta Momentum
Grail Inc (GRAL)
Fair Value-26.7% Downside
Overvalued
Analyst-5.5% Downside
Market Cap3.12 B
P/E-8.1x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
High-Beta Momentum
Sagimet Biosciences Inc (SGMT)
Fair Value-31.4% Downside
Overvalued
Analyst203.2% Upside
Market Cap493.4 M
P/E-12.3x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Beta Stocks
High-Beta Momentum
Small-Cap Stocks